PACS Group, Inc. (PACS) — the peer cohort

As of 2026-09-18 — scores re-bake nightly. Cohort = shared Closelook index membership first, then sector. Diary readings, not advice.

PACS Group, Inc. ranks 5 of 6 in its cohort on the Closelook composite (54/100) — the cohort is led by DexCom Inc at 66/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
PACS PACS Group, Inc. 54 73 39 54 info 14.9%
RHC.AU Ramsay Health Care Ltd 45 91 22 53 ok 1.1%
DXCM DexCom Inc 66 86 80 35 bull 5%
ARGX argenx NV ADR 64 79 74 27 ok 7.7%
ONC BeiGene, Ltd. 63 75 63 32 ok 8.9%
MEDP Medpace Holdings Inc 63 86 74 29 ok 9.7%

Scores are relative readings across the Closelook coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-09-18

Quick answers

Who are PACS Group, Inc.'s peers in the Closelook universe?

The cohort is drawn from shared Closelook index membership first, then sector: Ramsay Health Care Ltd (RHC.AU), DexCom Inc (DXCM), argenx NV ADR (ARGX), BeiGene, Ltd. (ONC), Medpace Holdings Inc (MEDP).

How does PACS score against its peers?

PACS Group, Inc.'s composite reads 54/100, ranking 5 of 6 in its cohort as of 2026-09-18; the cohort's highest composite is DexCom Inc at 66/100. Closelook scores are research diary readings, not ratings or advice.

Related in the Closelook universe

then Medical Care Facilities, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.